Loading
Naples medical device company Catalyst OrthoScience, focused on the shoulder replacement orthopedics market, has named industry veteran Amy Ables chief strategy officer.
Ables brings nearly 20 years of medical device experience to Catalyst, including more than a decade in upper extremity orthopedics, according to a statement. She has held leadership roles in sales, marketing, medical education and sales training at companies including Tornier, Wright Medical, ATEC Spine and Cutera. Prior to Cutera and through the peak of the COVID-19 pandemic, Ables, who has a doctorate, was the chief learning officer at Vyaire Medical, a global organization focused on respiratory care.
“I am grateful and excited to embrace this opportunity with the Catalyst team and to return to my professional roots in shoulder orthopedics,” Ables says in the statement. “I look forward to contributing with vigor and vision, steering our efforts toward growth and excellence with strategies that are both responsive to the present and attune to the necessary investments for our future success.”
“The board and I are excited to have an executive with Ables’ experience and leadership join our team at Catalyst OrthoScience,” Catalyst CEO and President Carl O’Connell adds in the statement.
Catalyst OrthoScience was founded in 2014 by orthopedic surgeon Dr. Steven Goldberg, seeing a need, the company says, “to make shoulder replacements less invasive, with fewer complications and a more natural-feeling shoulder after surgery.” It has a growing portfolio of patents and pending patents.
Your free article limit has been reached this month.
Subscribe now for unlimited digital access to our award-winning business news.
Join thousands of executives who rely on us for insights spanning Tampa Bay to Naples.
